BMO increases AbbVie stock target, outperform on upbeat …

On Thursday, BMO (TSX: BMO) Capital Markets adjusted its outlook on AbbVie Inc . (NYSE: …

CouponFollow Extension

$220.00
OFF

AbbVie (NYSE:ABBV) Price Target Increased To $220.00 By Analysts …

1 week from now

Oct 17, 2024 · BMO Capital Markets lifted their price target on AbbVie from $214.00 to $220.00 …

marketbeat.com

$220
OFF

AbbVie Price Target Raised To $220 From $214 At BMO Capital

1 week from now

Oct 18, 2024 · BMO Capital raised the firm’s price target on AbbVie to $220 from $214 and …

yahoo.com

$220
OFF

AbbVie Price Target Raised To $220 From $214 At BMO Capital

1 week from now

Oct 17, 2024 · A-. BMO Capital raised the firm’s price target on AbbVie to $220 from $214 and …

tipranks.com

$228
OFF

BMO Elevates AbbVie Stock Price Target On Strong Earnings

1 week from now

Oct 31, 2024 · The financial institution raised the stock's price target to $228 from a previous …

investorshangout.com

$215.00
OFF

BMO Capital Markets Issues Pessimistic Forecast For AbbVie …

1 week from now

5 days ago · Citigroup boosted their target price on shares of AbbVie from $215.00 to $226.00 …

marketbeat.com

$214
OFF

BMO Boosts Abbvie Shares Target Amid Positive Revenue Outlook

1 week from now

The new price target of $214 reflects a significant increase in the analyst's expectations for …

investing.com

FAQs about BMO increases AbbVie stock target, outperform on upbeat … Coupon?

Is AbbVie (abbv) stock overweight?

AbbVie (NYSE:ABBV) stock fell in early Thursday trade after CVS Health (NYSE:CVS) announced the removal of the drugmaker's Humira from most of its lists of covered medications for patients... An analyst from Wells Fargo maintained AbbVie (NYSE: ABBV) at 'overweight' with a price target of $180.00 from a prior price target of %currency%%price%. ...

Should you buy AbbVie (abbv)?

Out of the 18 analysts, 4 have given a hold rating, 13 have given a buy rating, and 1 has given a strong buy rating for ABBV. According to the 18 analysts' twelve-month price targets for AbbVie, the average price target is $198.47. The highest price target for ABBV is $225.00, while the lowest price target for ABBV is $150.00. ...

What is the price target for AbbVie (abbv)?

The highest price target for ABBV is $225.00, while the lowest price target for ABBV is $150.00. The average price target represents a forecasted upside of 5.08% from the current price of $188.87. Enter your email address to receive the latest news and analysts' ratings for AbbVie and its competitors. ...

Is AbbVie a good stock to buy?

AbbVie's strong portfolio of pharmaceutical products, including Humira, Skyrizi, Rinvoq, and Imbruvica, provides diversified revenue streams. Recent analyst ratings have been overwhelmingly positive, with multiple firms raising price targets and issuing buy ratings on AbbVie. ...

Why does AbbVie have a high debt-to-equity ratio?

AbbVie's consistent investment in research and development ensures a pipeline of innovative drugs that could drive future growth. AbbVie's high debt-to-equity ratio of 8.51 may pose a risk in case of economic downturns or financial instability. ...

Is AbbVie a Biopharmaceutical giant?

In recent months, AbbVie Inc (NYSE:ABBV). has captured Wall Street's attention, with analysts collectively painting a picture of a biopharmaceutical giant at a pivotal juncture. The... In the dynamic realm of biopharmaceuticals, AbbVie Inc . ...